RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11

Bicycle Therapeutics plc (NASDAQ:BCYC) is 1 of the

7 Fastest Growing European Stocks to Invest In. On March 18, 2026, RBC Capital lowered the terms people connected Bicycle Therapeutics plc (NASDAQ:BCYC) to $7 from $11 and maintained a Sector Perform rating, citing the company’s pivot distant from zelenectide arsenic a near-term setback that reduces visibility toward commercialization, though restructuring efforts could make meaningful outgo savings and enactment a longer-term reset.

On the aforesaid day, Oppenheimer expert Jay Olson lowered the terms people connected Bicycle Therapeutics plc (NASDAQ:BCYC) to $36 from $44 and maintained an Outperform rating, noting the company’s determination to deprioritize zelenectide-pevedotin contempt encouraging data, with resources being redirected toward BT5528 and next-generation programs, including its radio-conjugates portfolio.

On March 17, 2026, Bicycle Therapeutics plc (NASDAQ:BCYC) reported Q4 EPS of (29c), compared to the (95c) statement estimate, with gross of $47.96M versus $7.08M consensus. The institution said the summation successful gross was chiefly driven by designation of remaining collaboration gross pursuing termination notices with partners, including Novartis and Bayer. CEO Kevin Lee said the institution completed dose enactment successful the Duravelo-2 proceedings but, pursuing regulatory feedback, decided to deprioritize zelenectide for interior improvement and displacement absorption toward different pipeline programs, alongside a broader strategical reprioritization that includes a projected workforce reduction.

Copyright: dolgachov / 123RF Stock Photo

Bicycle Therapeutics plc (NASDAQ:BCYC) develops caller therapeutics for diseases with constricted attraction options.

While we admit the imaginable of BCYC arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.